Nearly 20% of fresh, frozen and canned fruits and vegetables that Americans eat contain concerning levels of pesticides, a new report finds. Pesticides posed significant risks in popular choices such as strawberries, green beans, bell peppers, blueberries and potatoes, the review from Consumer Reports found. “One food in particular, green beans, had residues of a… read on > read on >
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
Teens Often Bullied Online About Their Weight: Study
Teenagers are frequently bullied about their weight on social media, and the bullying increases with each hour they spend on these sites, a new study reveals. Nearly one in five teens (17%) said they’d experienced weight-related bullying online, according to results published April 17 in the journal PLOS One. “This experience can have adverse effects,… read on > read on >
Work That Challenges Your Brain Helps You Stay Sharp With Age
Jobs that challenge your mind could help your brain age more gracefully, a new study suggests. The harder your brain works on the job, the less likely you are to have memory and thinking problems later in life, researchers reported April 17 in the journal Neurology. “We examined the demands of various jobs and found… read on > read on >
Many Seniors Are Overmedicated, But ChatGPT Might Prevent That
AI could help doctors cut back on the bewildering variety of medications that seniors frequently are prescribed, a new study suggests. More than 40% of seniors are prescribed five or more meds, and this increases a person’s risk of adverse drug interactions, researchers said. When asked to evaluate faux medication lists of seniors, the OpenAI… read on > read on >
Antipsychotics May Do Great Harm to People With Dementia: Report
Antipsychotics can substantially increase dementia patients’ risk of many serious health problems, a new study warns. Dementia patients prescribed antipsychotics have increased risk of stroke, blood clots, heart attack, heart failure, bone fractures, pneumonia and kidney damage, researchers reported April 17 in the BMJ. “A move away from the overprescription of antipsychotics is overdue,” concluded… read on > read on >
Most Homeless Americans Are Battling Mental Illness
Two-thirds of homeless people are experiencing some form of mental health disorder, a large, new review of data on the subject. The analysis found that men who are homeless are more likely to be battling mental illness than women, although rates were high for both genders compared to the general population. There are signs that… read on > read on >
FDA Recalls Heart Failure Devices Linked to Injuries and Deaths
Two implanted heart devices used by patients in end-stage heart failure are now under a strict U.S. Food and Drug Administration recall, after being tied to 273 known injuries and 14 deaths, the agency said Tuesday. The HeartMate II and HeartMate 3 are manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories. About 14,000 of… read on > read on >
COVID Does Not Spur Asthma in Kids, Study Finds
There’s no evidence that a COVID infection increases the risk of asthma in children, the first study to date on the subject finds. “We knew from a number of really nice studies over the last decade or more that respiratory viral infections are a risk factor for the development of asthma in children,” said senior… read on > read on >
Birth Control Pill Might Lower Odds for Sports Injuries
Active women using the pill appear to receive an added bonus from their birth control, a new study says. These women are less likely to suffer sprains and strains than women not on birth control, researchers reported recently in the journal Medicine & Science in Sports & Exercise. Women taking oral contraceptives had significantly fewer… read on > read on >
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials
Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday. First approved to treat obesity by the U.S. Food and Drug Administration last November, Zepbound’s power was significant: It reduced sleep apnea severity by nearly… read on > read on >